Azacitidine prolongs overall survival in older patients with Acute Myeloid Leukemia (AML) with poor prognostic karyotypes - Doehner, H; Vyas, P; Seymour, JF; Santini, V; Stone, RM; Minden, MD; Al-Ali, HK; del Castillo, T; Morrill, J; Songer, S; Weaver, J; Skikne, BS; et al. (Elsevier, 2017)